Evidence map›Paper›PMID 37723174›Full record

ArticleNature communications2023

Structure of human drug transporters OATP1B1 and OATP1B3.

Anca-Denise Ciută, Kamil Nosol, Julia Kowal, Somnath Mukherjee, Ana S Ramírez, Bruno Stieger, Anthony A Kossiakoff, Kaspar P Locher

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Anca-Denise Ciută *Institute of Molecular Biology and Biophysics, Department of Biology, ETH Zürich, Zürich, Switzerland.
Kamil Nosol *Institute of Molecular Biology and Biophysics, Department of Biology, ETH Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-2865-9125
Julia Kowal *Institute of Molecular Biology and Biophysics, Department of Biology, ETH Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-4694-1896
Somnath Mukherjee *Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-5447-4496
Ana S RamírezInstitute of Molecular Biology and Biophysics, Department of Biology, ETH Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-1619-0721
Bruno StiegerInstitute of Molecular Biology and Biophysics, Department of Biology, ETH Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-7190-5785
Anthony A KossiakoffDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-3174-9359
Kaspar P LocherInstitute of Molecular Biology and Biophysics, Department of Biology, ETH Zürich, Zürich, Switzerland. locher@mol.biol.ethz.ch.ORCID http://orcid.org/0000-0002-8207-2889
ETH Zurich · CHUniversity of Chicago · US

Funding

Chaperone-Assisted Structure Determination of Membrane ProteinsR01GM117372 · NIGMS · UNIVERSITY OF CHICAGO · PI ANTHONY A KOSSIAKOFF · 2016 to 2026
$4.0M
NIGMS NIH HHS R01 GM117372
6 · The paper itself

Abstract

The organic anion transporting polypeptides OATP1B1 and OATP1B3 are membrane proteins that mediate uptake of drugs into the liver for subsequent conjugation and biliary excretion, a key step in drug elimination from the human body. Polymorphic variants of these transporters can cause reduced drug clearance and adverse drug effects such as statin-induced rhabdomyolysis, and co-administration of OATP substrates can lead to damaging drug-drug interaction. Despite their clinical relevance in drug disposition and pharmacokinetics, the structure and mechanism of OATPs are unknown. Here we present cryo-EM structures of human OATP1B1 and OATP1B3 bound to synthetic Fab fragments and in functionally distinct states. A single estrone-3-sulfate molecule is bound in a pocket located in the C-terminal half of OATP1B1. The shape and chemical nature of the pocket rationalize the preference for diverse organic anions and allow in silico docking of statins. The structure of OATP1B3 is determined in a drug-free state but reveals a bicarbonate molecule bound to the conserved signature motif and a histidine residue that is prevalent in OATPs exhibiting pH-dependent activity.

Indexed as

Liver-Specific Organic Anion Transporter 1Solute Carrier Organic Anion Transporter Family Member 1B3Biological TransportDrug-Related Side Effects and Adverse ReactionsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMembrane Transport ProteinsHydroxymethylglutaryl-CoA Reductase InhibitorsLiver-Specific Organic Anion Transporter 1Membrane Transport ProteinsSLCO1B1 protein, humanSLCO1B3 protein, humanSolute Carrier Organic Anion Transporter Family Member 1B3

Identifiers

PMID37723174
PMCPMC10507018
OpenAlexW4386830985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.